Unibios Holdings S.A.

As of December 31, 2024, Unibios Holdings S.A. carries a market capitalization of 26.95M, placing it among publicly traded companies globally. Its enterprise value stands at 31.18M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of December 31, 2024, Unibios Holdings S.A. has 16.89M shares outstanding.

These figures are as of December 31, 2024.

As of December 31, 2024, Unibios Holdings S.A. maintains a current ratio of 2.14, meaning it holds 2.1x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended December 31, 2024.

As of the close on October 22, 2026, Unibios Holdings S.A.'s stock has declined approximately 23.26% over the past 52 weeks. The 50-day moving average sits at 2.51, while the 200-day moving average is 2.60.

As of December 31, 2024, Unibios Holdings S.A. holds 3.09M in cash and equivalents against 7.32M in total debt, resulting in a net debt position of 3.96M. Total book value stands at 17.46M, with working capital of 8.41M providing operational flexibility.

Unibios Holdings S.A.'s most recent stock split took place on July 24, 2019 with a 157:185 split ratio.